vs

Side-by-side financial comparison of AGENUS INC (AGEN) and Arteris, Inc. (AIP). Click either name above to swap in a different company.

AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $20.1M, roughly 1.7× Arteris, Inc.). AGENUS INC runs the higher net margin — -31.0% vs -42.2%, a 11.2% gap on every dollar of revenue. On growth, Arteris, Inc. posted the faster year-over-year revenue change (30.0% vs 27.5%). Over the past eight quarters, Arteris, Inc.'s revenue compounded faster (24.7% CAGR vs 10.5%).

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

Arteris, Inc. is a multinational technology company headquartered in Campbell, California. It develops the network-on-chip (NoC) IP and system-on-chip (SoC) integration automation software that is used to create semiconductor chip and chiplet designs for a variety of devices, particularly in automotive electronics, artificial intelligence, machine learning, enterprise computing, communications, consumer, industrial, and aerospace & defense markets. The company specializes in the development a...

AGEN vs AIP — Head-to-Head

Bigger by revenue
AGEN
AGEN
1.7× larger
AGEN
$34.2M
$20.1M
AIP
Growing faster (revenue YoY)
AIP
AIP
+2.6% gap
AIP
30.0%
27.5%
AGEN
Higher net margin
AGEN
AGEN
11.2% more per $
AGEN
-31.0%
-42.2%
AIP
Faster 2-yr revenue CAGR
AIP
AIP
Annualised
AIP
24.7%
10.5%
AGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AGEN
AGEN
AIP
AIP
Revenue
$34.2M
$20.1M
Net Profit
$-10.6M
$-8.5M
Gross Margin
90.8%
Operating Margin
42.1%
-42.0%
Net Margin
-31.0%
-42.2%
Revenue YoY
27.5%
30.0%
Net Profit YoY
77.3%
-3.7%
EPS (diluted)
$0.09
$-0.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGEN
AGEN
AIP
AIP
Q4 25
$34.2M
$20.1M
Q3 25
$30.2M
$17.4M
Q2 25
$25.7M
$16.5M
Q1 25
$24.1M
$16.5M
Q4 24
$26.8M
$15.5M
Q3 24
$25.1M
$14.7M
Q2 24
$23.5M
$14.6M
Q1 24
$28.0M
$12.9M
Net Profit
AGEN
AGEN
AIP
AIP
Q4 25
$-10.6M
$-8.5M
Q3 25
$63.9M
$-9.0M
Q2 25
$-30.0M
$-9.1M
Q1 25
$-26.4M
$-8.1M
Q4 24
$-46.8M
$-8.2M
Q3 24
$-67.2M
$-7.7M
Q2 24
$-54.8M
$-8.3M
Q1 24
$-63.5M
$-9.4M
Gross Margin
AGEN
AGEN
AIP
AIP
Q4 25
90.8%
Q3 25
97.9%
89.9%
Q2 25
99.1%
89.4%
Q1 25
99.4%
90.8%
Q4 24
99.6%
89.8%
Q3 24
99.4%
90.1%
Q2 24
99.5%
90.0%
Q1 24
99.6%
88.7%
Operating Margin
AGEN
AGEN
AIP
AIP
Q4 25
42.1%
-42.0%
Q3 25
-15.0%
-50.1%
Q2 25
-65.0%
-50.0%
Q1 25
-55.3%
-46.6%
Q4 24
-96.5%
-45.9%
Q3 24
-125.5%
-53.8%
Q2 24
-128.4%
-51.1%
Q1 24
-117.4%
-70.5%
Net Margin
AGEN
AGEN
AIP
AIP
Q4 25
-31.0%
-42.2%
Q3 25
211.4%
-51.6%
Q2 25
-116.8%
-55.3%
Q1 25
-109.6%
-49.1%
Q4 24
-174.4%
-53.0%
Q3 24
-267.7%
-52.2%
Q2 24
-233.1%
-57.2%
Q1 24
-226.6%
-72.6%
EPS (diluted)
AGEN
AGEN
AIP
AIP
Q4 25
$0.09
$-0.19
Q3 25
$1.94
$-0.21
Q2 25
$-1.00
$-0.22
Q1 25
$-1.03
$-0.20
Q4 24
$-1.95
$-0.19
Q3 24
$-3.08
$-0.20
Q2 24
$-2.52
$-0.22
Q1 24
$-3.04
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGEN
AGEN
AIP
AIP
Cash + ST InvestmentsLiquidity on hand
$3.0M
$33.9M
Total DebtLower is stronger
$44.7M
Stockholders' EquityBook value
$-271.1M
$-14.6M
Total Assets
$226.8M
$115.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGEN
AGEN
AIP
AIP
Q4 25
$3.0M
$33.9M
Q3 25
$3.5M
$39.0M
Q2 25
$9.5M
$38.0M
Q1 25
$18.5M
$42.3M
Q4 24
$40.4M
$43.8M
Q3 24
$44.8M
$48.7M
Q2 24
$93.7M
$45.8M
Q1 24
$52.9M
$44.8M
Total Debt
AGEN
AGEN
AIP
AIP
Q4 25
$44.7M
Q3 25
$34.2M
Q2 25
$33.9M
Q1 25
$33.6M
Q4 24
$33.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AGEN
AGEN
AIP
AIP
Q4 25
$-271.1M
$-14.6M
Q3 25
$-274.1M
$-11.4M
Q2 25
$-354.6M
$-7.5M
Q1 25
$-341.8M
$-4.8M
Q4 24
$-326.4M
$-1.2M
Q3 24
$-292.3M
$2.2M
Q2 24
$-241.3M
$5.3M
Q1 24
$-201.4M
$9.5M
Total Assets
AGEN
AGEN
AIP
AIP
Q4 25
$226.8M
$115.0M
Q3 25
$233.9M
$107.7M
Q2 25
$185.2M
$106.9M
Q1 25
$200.2M
$98.3M
Q4 24
$226.3M
$106.1M
Q3 24
$238.5M
$97.7M
Q2 24
$292.4M
$96.4M
Q1 24
$256.6M
$101.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGEN
AGEN
AIP
AIP
Operating Cash FlowLast quarter
$-16.6M
$3.2M
Free Cash FlowOCF − Capex
$3.0M
FCF MarginFCF / Revenue
15.1%
Capex IntensityCapex / Revenue
0.0%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGEN
AGEN
AIP
AIP
Q4 25
$-16.6M
$3.2M
Q3 25
$-14.7M
$3.2M
Q2 25
$-20.2M
$-2.5M
Q1 25
$-25.6M
$2.9M
Q4 24
$-28.7M
$-2.6M
Q3 24
$-53.3M
$1.1M
Q2 24
$-38.2M
$311.0K
Q1 24
$-38.2M
$477.0K
Free Cash Flow
AGEN
AGEN
AIP
AIP
Q4 25
$3.0M
Q3 25
$2.5M
Q2 25
$-20.2M
$-2.8M
Q1 25
$-25.6M
$2.7M
Q4 24
$-28.7M
$-2.7M
Q3 24
$-53.3M
$1.1M
Q2 24
$-38.6M
$264.0K
Q1 24
$-38.2M
$281.0K
FCF Margin
AGEN
AGEN
AIP
AIP
Q4 25
15.1%
Q3 25
14.2%
Q2 25
-78.7%
-17.2%
Q1 25
-106.5%
16.2%
Q4 24
-107.0%
-17.3%
Q3 24
-212.2%
7.4%
Q2 24
-164.4%
1.8%
Q1 24
-136.5%
2.2%
Capex Intensity
AGEN
AGEN
AIP
AIP
Q4 25
0.0%
0.7%
Q3 25
0.0%
4.1%
Q2 25
0.0%
2.2%
Q1 25
0.0%
1.1%
Q4 24
0.3%
0.3%
Q3 24
0.0%
0.2%
Q2 24
2.0%
0.3%
Q1 24
0.1%
1.5%
Cash Conversion
AGEN
AGEN
AIP
AIP
Q4 25
Q3 25
-0.23×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGEN
AGEN

Non Cash Royalty Revenue$31.1M91%
Other$3.2M9%

AIP
AIP

License And Maintenance$17.5M87%
Variable Royalties And Other$2.6M13%

Related Comparisons